BlackRock’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $625M | Sell |
|
|||||
|
2025
Q2 | $532M | Sell |
|
|||||
|
2025
Q1 | $471M | Sell |
|
|||||
|
2024
Q4 | $382M | Sell |
|
|||||
|
2024
Q3 | $460M | Buy |
|
|||||
|
2024
Q2 | $200M | Buy |
|
|||||
|
2024
Q1 | $161M | Buy |
|
|||||
|
2023
Q4 | $127M | Buy |
|
|||||
|
2023
Q3 | $87.2M | Buy |
|
|||||
|
2023
Q2 | $138M | Buy |
|
|||||
|
2023
Q1 | $101M | Buy |
|
|||||
|
2022
Q4 | $39.8M | Buy |
|
|||||
|
2022
Q3 | $29.2M | Buy |
|
|||||
|
2022
Q2 | $27.3M | Buy |
|
|||||
|
2022
Q1 | $76.9M | Sell |
|
|||||
|
2021
Q4 | $112M | Buy |
|
|||||
|
2021
Q3 | $56.7M | Buy |
|
|||||
|
2021
Q2 | $136M | Buy |
|
|||||
|
2021
Q1 | $77.7M | Buy |
|
|||||
|
2020
Q4 | $52.2M | Buy |
|
|||||
|
2020
Q3 | $48M | Buy |
|
|||||
|
2020
Q2 | $36.1M | Buy |
|
|||||
|
2020
Q1 | $11M | Sell |
|
|||||
|
2019
Q4 | $11M | Buy |
|
|||||
|
2019
Q3 | $13M | Buy |
|
|||||
|
2019
Q2 | $12.3M | Buy |
|
|||||
|
2019
Q1 | $3.44M | Buy |
|
|||||
|
2018
Q4 | $1.75M | Buy |
|
|||||
|
2018
Q3 | $2.46M | Sell |
|
|||||
|
2018
Q2 | $1.71M | Sell |
|
|||||
|
2018
Q1 | $5.9M | Buy |
|
|||||
|
2017
Q4 | $10.3M | Buy |
|
|||||
|
2017
Q3 | $7.91M | Buy |
|
|||||
|
2017
Q2 | $4.88M | Buy |
|
|||||
|
2017
Q1 | $4.43M | Buy |
|
|||||
|
2016
Q4 | $6K | Buy |
|